A large population-based cohort study examining cases where primary Epstein-Barr virus (EBV) infection occurred *after* the onset of multiple sclerosis (MS), challenging the prevailing assumption that EBV infection always precedes MS.
Only the abstract is available — full text could not be retrieved. Specific results, sample sizes, effect sizes, and methodological details are unknown.
